0 0 Edinburgh Cardiothoracic Surgeons Limited SC477619 false 2024-06-01 2025-05-31 2025-05-31 The principal activity of the company is Post graduate education and medical consultancy services. Digita Accounts Production Advanced 6.30.9574.0 true SC477619 2024-06-01 2025-05-31 SC477619 2025-05-31 SC477619 core:RetainedEarningsAccumulatedLosses 2025-05-31 SC477619 core:ShareCapital 2025-05-31 SC477619 core:CurrentFinancialInstruments 2025-05-31 SC477619 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2025-05-31 SC477619 bus:SmallEntities 2024-06-01 2025-05-31 SC477619 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 SC477619 bus:FilletedAccounts 2024-06-01 2025-05-31 SC477619 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 SC477619 bus:RegisteredOffice 2024-06-01 2025-05-31 SC477619 bus:Director1 2024-06-01 2025-05-31 SC477619 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2024-06-01 2025-05-31 SC477619 core:OfficeEquipment 2024-06-01 2025-05-31 SC477619 countries:Scotland 2024-06-01 2025-05-31 SC477619 2024-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2024-05-31 SC477619 2023-06-01 2024-05-31 SC477619 2024-05-31 SC477619 core:RetainedEarningsAccumulatedLosses 2024-05-31 SC477619 core:ShareCapital 2024-05-31 SC477619 core:CurrentFinancialInstruments 2024-05-31 SC477619 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 SC477619 core:CurrentFinancialInstruments core:WithinOneYear core:PreviouslyStatedAmount 2024-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2024-05-31 SC477619 core:PreviouslyStatedAmount 2024-05-31 xbrli:pure iso4217:GBP

Registration number: SC477619

Edinburgh Cardiothoracic Surgeons Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 May 2025

Edinburgh Cardiothoracic Surgeons Limited

Contents

Balance Sheet | 1
Notes to the Unaudited Financial Statements | 2 to 4

Edinburgh Cardiothoracic Surgeons Limited

(Registration number: SC477619)
Balance Sheet as at 31 May 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 4,689 | 5,056
Current assets |  |  |
Debtors |  | - | 126
Cash at bank and in hand |  | 183,724 | 187,778
|  | 183,724 | 187,904
Creditors: Amounts falling due within one year | 5 | (10,841) | (21,005)
Net current assets |  | 172,883 | 166,899
Total assets less current liabilities |  | 177,572 | 171,955
Provisions for liabilities |  | (891) | (961)
Net assets |  | 176,681 | 170,994
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Retained earnings |  | 176,581 | 170,894
Shareholders' funds |  | 176,681 | 170,994

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 3 February 2026

......................................... Mr Vipin Zamvar Director

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

1 | General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
12 Redhall House Avenue
Edinburgh
Midlothian
EH14 1JJ

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office equipment | 20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 June 2024 | 21,560 | 21,560
Additions | 1,690 | 1,690
At 31 May 2025 | 23,250 | 23,250
Depreciation
At 1 June 2024 | 16,504 | 16,504
Charge for the year | 2,057 | 2,057
At 31 May 2025 | 18,561 | 18,561
Carrying amount
At 31 May 2025 | 4,689 | 4,689
At 31 May 2024 | 5,056 | 5,056

5 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Directors loan |  | 1,625 | 13,222
Taxation and social security |  | 1,074 | 1,143
Other creditors |  | 8,142 | 6,640
|  | 10,841 | 21,005